Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 31/5/2020
SIETES contiene 93020 citas

<< anterior 21 a 31 de 31 
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas Cita con resumen
Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, Williams H, and the ISAAC Phase Three Study Group. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368:733-43. [Ref.ID 77954]
22. Cita con resumen
Bass E. Uganda is learning from its Global Fund grant suspension. Lancet 2005;366:1839-40. [Ref.ID 75508]
23.Tiene citas relacionadas Cita con resumen
Rogan WJ, Chen A. Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT). Lancet 2005;366:763-73. [Ref.ID 74687]
24. Cita con resumen
Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56. [Ref.ID 70776]
25. Cita con resumen
McMichael AJ, McKee M, Shkolnikov V, Valkonen T. Mortality trends and setbacks: global convergence or divergence?. Lancet 2004;363:1155-9. [Ref.ID 69707]
26.Tiene citas relacionadas
Schofield I, Faigen N. Generics gets to priority. Scrip Magazine 2004;131:30-2. [Ref.ID 69227]
27.Tiene citas relacionadas
Sukkar E. Single digit growth continues. Scrip Magazine 2004;131:22-3. [Ref.ID 69226]
29. Cita con resumen
Mann JI. Diet and risk of coronary heart disease and type 2 diabetes. Lancet 2002;360:783-9. [Ref.ID 63247]
30. Cita con resumen
Krosnar K. One in three children malnourised in parts of Europe. BMJ 2001;323:1326. [Ref.ID 59650]
31. Cita con resumen
Darbourne A. Healthy growth for world pharma sales. Scrip Magazine 2000;87:34-6. [Ref.ID 49125]
Seleccionar todas
<< anterior 21 a 31 de 31